Wire

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

News Plus

Welcome, one more step

The cross-newsroom layer: who covered a story, who didn’t, and how each one worded it. Plus your own news, on every device.

Follow your news

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email

See the coverage

  • Headlines side by side
  • Who reported first
  • Every newsroom clip, from every platform
  • Every newsroom photo on a story

Go deeper

  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Wire

Free stays free: the live wire, Not Everywhere, the brief, five follows and five Duki questions a day.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

News Plus · Ask Duki

Keep asking Duki

A free account gets five questions a day. News Plus lifts the daily limit.

Also in News Plus

  • The whole archive
  • Headlines side by side
  • Who reported first
  • The Desk, every hour

developing· Health· Updated

Israel Recalls Specific Drug Batch Due to Rare Hypersensitivity Reactions

Israel's Ministry of Health and distributor Medici Medical are voluntarily recalling a specific batch of Flebogamma 5% DIF due to an increased incidence of hypersensitivity reactions. Other batches remain safe for use, and alternative treatments are available.

3 newsrooms · 2 languages · since

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

Israel Recalls Specific Drug Batch Due to Rare Hypersensitivity Reactions
Illustration by baba

What happened

  1. 01Israel's Ministry of Health and Medici Medical recalled a specific batch of Flebogamma 5% DIF.
  2. 02The recall is due to an unusually high frequency of hypersensitivity reactions reported.
  3. 03All other batches of the drug remain safe and available for patient use.
  4. 04The recall is a precautionary measure, and alternative treatments are available.
  5. 05The affected batch must be returned to the "Sosna" trading house for compensation.

The recall affects distribution channels from pharmacies to warehouses, with procedures in place for returning the affected product for compensation.

Translated and summarized by baba from Cursorinfo, the latest report. Read Cursorinfo’s original

The coverage

3 newsrooms on this story

Who covered it

  • LeftNone
  • CentreNone
  • RightNone
  • HarediNone
  • ArabNone
  • Other2

How it broke

Plus

News Plus · Who reported first

See which newsroom broke it

The order the newsrooms filed in, and how long each side of the press waited before running the story.

Also in News Plus

  • Headlines side by side
  • Story alerts
  • The Wire
  • Unlimited follows

How it reads

Neutral tone, on average across the newsrooms

How temperature and stance are measured